Probiotics for Irritable Bowel Syndrome

Last updated: July 18, 2016
Sponsor: Norwegian University of Science and Technology
Overall Status: Completed

Phase

N/A

Condition

Lactose Intolerance

Colic

Ulcers

Treatment

N/A

Clinical Study ID

NCT00355810
REK 4.2005.2284
  • Ages 18-75
  • All Genders

Study Summary

This randomised, double blind, cross-over study compares the effect (symptoms, fecal bacterial growth, gas production) of three weeks' treatment with lactobacillus plantarum MF 1298 with placebo in patients with irritable bowel syndrome. The results are related to dietary habits, food intolerance and food allergy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Irritable bowel syndrome according to the Rome II criteria

  • regular symptoms

Exclusion

Exclusion Criteria:

  • Use of probiotics last three weeks

  • pregnancy

  • lactation

  • co-existing other gastrointestinal disorders

  • use of laxatives and antibiotics within last 5 weeks.

Study Design

Total Participants: 19
Study Start date:
January 01, 2006
Estimated Completion Date:
December 31, 2006

Connect with a study center

  • Innlandet Hospital HF

    Gjovik, Oppland N-2819
    Norway

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.